Table 5.
Household treatment expenditure per ADR episode (2005 USD)
|
Expenses for patients with and without expenditures | ||||
|---|---|---|---|---|
| Number of episodes | Mean* | Median# | Range | |
| Episodes with complete cost information (with and without expenses) |
50 |
24.15 |
10 |
0.00 – 226.04 |
|
ADR Classification: | ||||
| Probable |
31 |
28.85 |
14.61~ |
0.00 –226.04 |
| Possible |
19 |
16.48 |
3.48~ |
0.00 – 115.91 |
|
Treatment costs by admission status: | ||||
| Admitted |
22 |
47.18** |
30.83** |
0.00 – 226.04 |
| Not admitted |
28 |
6.05** |
2.61** |
0.00 – 35.39 |
|
Treatment costs by survivorship | ||||
| Costs for patients surviving |
43 |
17.15 |
7.80^ |
0.00 – 125.87 |
| Costs for Patients dying |
7 |
63.89 |
28.74^ |
0.00 – 226.04 |
|
Number of visits: | ||||
| One |
30 |
7.24** |
2.23^ |
0.00 – 44.04 |
| Two |
15 |
32.01** |
28.74^ |
1.74 – 115.91 |
| Three |
3 |
72.09 |
46.48 |
43.91 – 125.87 |
| Four |
2 |
146.93** |
146.93^ |
67.83 – 226.04 |
|
Study district: | ||||
| Rufiji |
28 |
21.68 |
3.61^ |
0.00 – 226.04 |
| Kilombero / Ulanga |
22 |
27.29 |
21.80^ |
0.00 – 115.91 |
|
Age group: | ||||
| Under 5 years |
13 |
11.60 |
5.99 |
0 – 32.91 |
| 5 years or over |
37 |
28.11 |
10.78 |
0 – 226.04 |
|
By drug use | ||||
| AS only |
1 |
9.74 |
9.74^ |
9.74 – 9.74 |
| SP only |
35 |
29.02 |
19.61^ |
0 – 226.04 |
| SP + Artesunate | 14 | 13.00 | 3.61^ | 0 – 125.87 |
Note: *Students t-test between groups &#Wilcoxon rank sum (Mann- Whitney) test.
**Significant between one and four visits, and between two and four visits at 1% level.
^Significant between groups and/or between one and four visits and between two and four visits at 5% level.
~Significant between groups and/or between one and four visits, and between two and four visits at 10% level.